Zhongchao (NASDAQ:ZCMD) Stock Rating Cut to “Sell” at Wall Street Zen

Wall Street Zen lowered shares of Zhongchao (NASDAQ:ZCMD) from a hold rating to a sell rating in a research report sent to investors on Sunday,Wall Street Zen reports.

Separately, Weiss Ratings lowered Zhongchao from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, September 25th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company has an average rating of “Sell”.

Zhongchao Price Performance

NASDAQ ZCMD opened at $1.59 on Friday. Zhongchao has a 1 year low of $1.42 and a 1 year high of $1,443.36. The business’s fifty day moving average is $1.84 and its two-hundred day moving average is $110.57.

Zhongchao Company Profile

Zhongchao Inc (NASDAQ:ZCMD) is a China-based healthcare technology company that provides online healthcare information and education services. Its platform is designed to connect medical professionals with educational content, industry information and other digital resources.

The company focuses on supporting healthcare professionals through continuing medical education and related online programs, with an emphasis on improving access to medical knowledge and professional development. Zhongchao also provides health-related information and services intended to support patients and broader healthcare communication.

Zhongchao primarily serves healthcare professionals, patients and other participants in China’s healthcare sector through its digital platforms.